Artal Group S.A. Solid Biosciences Inc. Put Options Transaction History
Artal Group S.A.
- $1.58 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SLDB
# of Institutions
2Shares Held
97Call Options Held
0Put Options Held
0About Solid Biosciences Inc.
- Ticker SLDB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,533,080
- Market Cap $53.2M
- Description
- Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...